Of the 47 men who had TURP surgery, about 1 in 8 had bleeding, some got a urinary infection or clots blocking their urine, and 3 needed a blood transfusion.
Scientific Claim
Among 47 men undergoing TURP for BPH, bleeding occurred in 12%, urinary tract infection (UTI) and clot retention were common complications, and 3 patients (6.3%) required blood transfusion.
Original Statement
“The common complications were bleeding (12%), UTI and clot retention. Blood transfusion was required in 3 patients (6.3%).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design cannot support claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim reports observed complication frequencies without implying causation or generalizability. The language matches the abstract’s descriptive nature. However, the study design cannot support claims about how common these are in all populations.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aThe pooled incidence of bleeding, UTI, and clot retention after TURP across diverse populations to establish benchmark complication rates.
The pooled incidence of bleeding, UTI, and clot retention after TURP across diverse populations to establish benchmark complication rates.
What This Would Prove
The pooled incidence of bleeding, UTI, and clot retention after TURP across diverse populations to establish benchmark complication rates.
Ideal Study Design
A meta-analysis of ≥15 prospective studies reporting complication rates after TURP in men aged 60–85 with BPH, using standardized definitions for bleeding (≥2 units transfused), UTI (culture-proven), and clot retention (requiring catheter irrigation).
Limitation: Cannot determine if rates are due to technique, patient selection, or center experience.
Prospective Cohort StudyLevel 2bIncidence and predictors of bleeding, UTI, and clot retention after TURP in a standardized population.
Incidence and predictors of bleeding, UTI, and clot retention after TURP in a standardized population.
What This Would Prove
Incidence and predictors of bleeding, UTI, and clot retention after TURP in a standardized population.
Ideal Study Design
A prospective cohort of 300+ men aged 60–80 undergoing TURP, with daily monitoring for 30 days for defined complications, recording preoperative anticoagulant use, prostate size, and surgeon experience.
Limitation: Cannot isolate whether complications are due to surgery or patient factors.
Case-Control StudyLevel 3bWhether specific factors (e.g., prostate size, anticoagulants) are associated with higher bleeding risk after TURP.
Whether specific factors (e.g., prostate size, anticoagulants) are associated with higher bleeding risk after TURP.
What This Would Prove
Whether specific factors (e.g., prostate size, anticoagulants) are associated with higher bleeding risk after TURP.
Ideal Study Design
A case-control study comparing 50 patients with post-TURP bleeding (≥2 units transfused) to 100 without, matched for age and prostate volume, assessing preoperative medications, coagulation status, and surgical technique.
Limitation: Cannot prove causation; subject to recall and selection bias.
Evidence from Studies
Supporting (1)
This study looked at 47 men who had a common prostate surgery called TURP, and it found exactly what the claim says: 12% bled, some got infections or clots, and 3 needed blood transfusions. So the claim is correct.